Product Information
TESTOSTERONE CYP 2,000 MG/10 ML is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $3.5819 per ML under NDC 00143900501. Its NADAC has been published 233 times since Apr 20, 2022.
FDA first approved this application on May 1, 2012. Its Orange Book therapeutic-equivalence code is AO.
Strength
200 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143900501
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONE CYPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA091244FDA Approved
5/1/2012
TE Code
AO
On Market Since
11/22/2021
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE CYP 2,000 MG/10 ML has been published 233 times since Apr 20, 2022, and over the history we have for it it has risen 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5819 per ML |
|---|---|
| All-time high | $4.3016 (Sep 13, 2023) |
| All-time low | $3.0960 (Sep 21, 2022) |
| 52-week high | $3.6508 |
| 52-week low | $3.2594 |
| Median price | $3.5162 |
| Average price | $3.6116 |
| Largest weekly change | +19.9% (Apr 19, 2023) |
| Weeks tracked | 233 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Testosterone Cypionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE CYP 2,000 MG/10 ML?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE CYP 2,000 MG/10 ML, manufactured by Hikma Pharmaceuticals USA Inc., is $3.5819 per ML (NDC 00143900501), effective Sep 30, 2026.
How has the price of TESTOSTERONE CYP 2,000 MG/10 ML changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE CYP 2,000 MG/10 ML has risen 8.0%. It has been tracked across 233 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE CYP 2,000 MG/10 ML?
Since Apr 20, 2022, the NADAC for TESTOSTERONE CYP 2,000 MG/10 ML has ranged from a low of $3.0960 (Sep 21, 2022) to a high of $4.3016 (Sep 13, 2023), with a median of $3.5162 per ML.
Are there cheaper alternatives to TESTOSTERONE CYP 2,000 MG/10 ML?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TESTOSTERONE CYP 2,000 MG/10 ML, is $3.2859 per ML — about 8% below TESTOSTERONE CYP 2,000 MG/10 ML.
Who manufactures TESTOSTERONE CYP 2,000 MG/10 ML?
TESTOSTERONE CYP 2,000 MG/10 ML (NDC 00143900501) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.